GMCQX
Price
$15.23
Change
+$0.05 (+0.33%)
Updated
Dec 3 closing price
Net Assets
208.17M
VVIAX
Price
$74.33
Change
+$0.66 (+0.90%)
Updated
Dec 3 closing price
Net Assets
207.95B
Interact to see
Advertisement

GMCQX vs VVIAX

Header iconGMCQX vs VVIAX Comparison
Open Charts GMCQX vs VVIAXBanner chart's image
GMO US Equity VI
Price$15.23
Change+$0.05 (+0.33%)
VolumeN/A
Net Assets208.17M
Vanguard Value Index Adm
Price$74.33
Change+$0.66 (+0.90%)
VolumeN/A
Net Assets207.95B
GMCQX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
GMCQX vs. VVIAX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMCQX is a Buy and VVIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 208B vs. GMCQX (208M). VVIAX pays higher dividends than GMCQX: VVIAX (2.04) vs GMCQX (0.99). GMCQX was incepted earlier than VVIAX: GMCQX (22 years) vs VVIAX (25 years). GMCQX (0.50) is less costly to investors than VVIAX (0.05). GMCQX is a more actively managed with annual turnover of: 89.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than GMCQX: VVIAX (3000) vs GMCQX (300000000). VVIAX annual gain was more profitable for investors over the last year : 6.10 vs. GMCQX (3.39). VVIAX return over 5 years is better than : 60.40 vs. GMCQX (19.70).
GMCQXVVIAXGMCQX / VVIAX
Total Expense Ratio0.400.05800%
Annual Report Gross Expense Ratio0.500.051,000%
Fund Existence22 years25 years-
Gain YTD16.19912.640128%
Front LoadN/AN/A-
Min. Initial Investment300000000300010,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets208M208B0%
Annual Yield % from dividends0.992.0448%
Returns for 1 year3.396.1056%
Returns for 3 years24.1830.8278%
Returns for 5 years19.7060.4033%
Returns for 10 years13.32128.9010%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALLO1.520.18
+13.43%
Allogene Therapeutics
BCAB0.830.05
+6.00%
BioAtla
AGIO27.490.51
+1.89%
Agios Pharmaceuticals
WTGUU10.30N/A
N/A
Wintergreen Acquisition Corp.
UGI37.64-0.49
-1.29%
UGI Corp